Glenn D. Prestwich is currently the President’s Distinguished Professor at Washington State University, based at the WSU Health Sciences Spokane campus, and founding director of WSU’s Entrepreneurial Faculty Ambassador program. He is also Presidential Professor of Medicinal Chemistry (Emeritus) and Presidential Special Assistant for Faculty Entrepreneurism (Emeritus) at the University of Utah, where he created and led the Entrepreneurial Faculty Scholars program. In 2016, he and led the External Review of Innovation and Entrepreneurship at WSU, and is now implementing the recommendations of that review. He also serves as the Chief Science Officer of the preclinical company GlycoMira Therapeutics. His research includes phospholipids in cell signaling, synthetic matrices for regenerative medicine, and anti-inflammatory glycosaminoglycans. He co-founded nine companies, including Echelon Biosciences, Glycosan BioSystems, Sentrx Animal Care, GlycoMira Therapeutics, and Deuteria Biomaterials. He is a 2018 Fellow of the AAAS, a 2013 Fellow of the National Academy of Inventors, recipient of the 2006 Utah Governor’s Medal for Science and Technology, the 2008 Volwiler Research Award of the AACP, the 2010 University of Utah Distinguished Scholarly and Creative Research Award, and the 2014 U of Utah Distinguished Innovation and Impact Award. During 42 years as a faculty member, he has over 650 publications (H-index 94) and over 40 issued patents and has trained over 125 postgraduate scientists. He is a pilot and an advocate for chamber music.

As a PhD in human genetics with an MBA emphasizing strategy and operations, Michaele currently works to cultivate growth in the bioscience industry across Oregon, Eastern Washington and Northern Idaho. Michaele is a seasoned researcher and project manager with a proven track record of finding solutions for world-class bioscience companies (including Biotronik, McKesson, and Philips), startups, and leading research institutions. She has broad and deep experience in delivering data driven decision making from the perspectives of academic medicine and industry. She enjoys establishing and developing relationships with industry and academia with the end goal of enabling technologies to improve health outcomes.

Highlights:
• Skilled program and project manager
• Easily work in teams or independently to optimize outcomes
• Technology transfer experience including technology evaluation, market analysis and marketing of technologies
• Bioscience consulting experience
• 15 years of experience in bench and clinical oncology research
• 30+ peer reviewed publications